- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Achromobacter.
Displaying page 1 of 1.
| EudraCT Number: 2018-001590-24 | Sponsor Protocol Number: 01.01.18 | Start Date*: 2019-03-21 | |||||||||||
| Sponsor Name:University of Dundee [...] | |||||||||||||
| Full Title: A Trial of the Safety, Tolerability and Efficacy of 2 doses of Cayston (Aztreonam Lysine) compared to placebo in participants with bronchiectasis. | |||||||||||||
| Medical condition: Bronchiectasis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Temporarily Halted) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2016-001785-29 | Sponsor Protocol Number: ARIS2 | Start Date*: 2016-08-15 |
| Sponsor Name:St. Vincent's University Hospital | ||
| Full Title: Combined Effect of CFTR Modifiers and Intensive Antibiotic Treatment | ||
| Medical condition: Cystic fibrosis | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: IE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-002677-38 | Sponsor Protocol Number: CTX-4430-CF-201 | Start Date*: 2016-02-04 | ||||||||||||||||
| Sponsor Name:Celtaxsys Inc. | ||||||||||||||||||
| Full Title: A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks... | ||||||||||||||||||
| Medical condition: Cystic Fibrosis | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: GB (Completed) DE (Completed) IT (Completed) BE (Completed) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2019-000325-49 | Sponsor Protocol Number: CQBW251B2202 | Start Date*: 2020-04-09 | |||||||||||
| Sponsor Name:Novartis Pharma AG | |||||||||||||
| Full Title: A randomized, subjects and investigator blinded, placebo controlled parallel group study to assess the mode of action of QBW251 in patients with Chronic Obstructive Pulmonary Disease (COPD) | |||||||||||||
| Medical condition: Chronic obstructive pulmonary disease | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Temporarily Halted) GB (GB - no longer in EU/EEA) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.